RESUMO
We have sequenced a contiguous 284,495-bp segment of DNA extending from the terminal (TTAGGG)n repeats of the short arm of chromosome 16, providing a full description of the transition from telomeric through subtelomeric DNA to sequences that are unique to the chromosome. To complement and extend analysis of the primary sequence, we have characterized mRNA transcripts, patterns of DNA methylation and DNase I sensitivity. Together with previous data these studies describe in detail the structural and functional organization of a human telomeric region.
Assuntos
Cromossomos Humanos Par 16 , Sequências Repetitivas de Ácido Nucleico , Telômero , Sequência de Bases , Mapeamento Cromossômico , DNA/química , DNA/genética , Desoxirribonuclease I , Repetições de Dinucleotídeos , Marcadores Genéticos , Humanos , Repetições Minissatélites , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , RNA Mensageiro/biossíntese , Transcrição GênicaRESUMO
A goal of molecular genetics is to understand the relationship between basic nuclear processes, epigenetic changes and the numerous proteins that orchestrate these effects. One such protein, ATRX, contains a highly conserved plant homeodomain (PHD)-like domain, present in many chromatin-associated proteins, and a carboxy-terminal domain which identifies it as a member of the SNF2 family of helicase/ATPases. Mutations in ATRX give rise to characteristic developmental abnormalities including severe mental retardation, facial dysmorphism, urogenital abnormalities and alpha-thalassaemia. This circumstantial evidence suggests that ATRX may act as a transcriptional regulator through an effect on chromatin. We have recently shown that ATRX is localized to pericentromeric heterochromatin during interphase and mitosis, suggesting that ATRX might exert other chromatin-mediated effects in the nucleus. Moreover, at metaphase, some ATRX is localized at or close to the ribosomal DNA (rDNA) arrays on the short arms of human acrocentric chromosomes. Here we show that mutations in ATRX give rise to changes in the pattern of methylation of several highly repeated sequences including the rDNA arrays, a Y-specific satellite and subtelomeric repeats. Our findings provide a potential link between the processes of chromatin remodelling, DNA methylation and gene expression in mammalian development.
Assuntos
DNA Helicases , Metilação de DNA , Proteínas de Ligação a DNA/genética , Mutação , Proteínas Nucleares , Fatores de Transcrição/genética , Southern Blotting , Ilhas de CpG/genética , Análise Mutacional de DNA , DNA Ribossômico/genética , DNA Ribossômico/metabolismo , DNA Satélite/genética , Regulação para Baixo/genética , Técnica Indireta de Fluorescência para Anticorpo , Globinas/biossíntese , Globinas/genética , Humanos , Deficiência Intelectual/genética , Sequências Repetitivas de Ácido Nucleico/genética , Síndrome , Telômero/genética , Cromossomo X/genética , Proteína Nuclear Ligada ao X , Talassemia alfa/genéticaRESUMO
Determining the mechanisms by which genes are switched on and off during development is a key aim of current biomedical research. Gene transcription has been widely observed to occur in a discontinuous fashion, with short bursts of activity interspersed with periods of inactivity. It is currently not known if or how this dynamic behaviour changes as mammalian cells differentiate. To investigate this, using an on-microscope analysis, we monitored mouse α-globin transcription in live cells throughout erythropoiesis. We find that changes in the overall levels of α-globin transcription are most closely associated with changes in the fraction of time a gene spends in the active transcriptional state. We identify differences in the patterns of transcriptional bursting throughout differentiation, with maximal transcriptional activity occurring in the mid-phase of differentiation. Early in differentiation, we observe increased fluctuation in transcriptional activity whereas at the peak of gene expression, in early erythroblasts, transcription is relatively stable. Later during differentiation as α-globin expression declines, we again observe more variability in transcription within individual cells. We propose that the observed changes in transcriptional behaviour may reflect changes in the stability of active transcriptional compartments as gene expression is regulated during differentiation.
Assuntos
Eritroblastos , Eritropoese , Camundongos , Animais , Eritroblastos/metabolismo , Diferenciação Celular/genética , Eritropoese/genética , Cromatina/metabolismo , alfa-Globinas/genética , alfa-Globinas/metabolismo , Transcrição Gênica , Globinas/genética , Mamíferos/genéticaRESUMO
The alpha- and beta-globin gene clusters have been extensively studied. Regulation of these genes ensures that proteins derived from both loci are produced in balanced amounts, and that expression is tissue-restricted and specific to developmental stages. Here we compare the subnuclear location of the endogenous alpha- and beta-globin loci in primary human cells in which the genes are either actively expressed or silent. In erythroblasts, the alpha- and beta-globin genes are localized in areas of the nucleus that are discrete from alpha-satellite-rich constitutive heterochromatin. However, in cycling lymphocytes, which do not express globin genes, the distribution of alpha- and beta-globin genes was markedly different. beta-globin loci, in common with several inactive genes studied here (human c-fms and SOX-1) and previously (mouse lambda5, CD4, CD8alpha, RAGs, TdT and Sox-1), were associated with pericentric heterochromatin in a high proportion of cycling lymphocytes. In contrast, alpha-globin genes were not associated with centromeric heterochromatin in the nucleus of normal human lymphocytes, in lymphocytes from patients with alpha-thalassaemia lacking the regulatory HS-40 element or entire upstream region of the alpha-globin locus, or in mouse erythroblasts and lymphocytes derived from human alpha-globin transgenic mice. These data show that the normal regulated expression of alpha- and beta-globin gene clusters occurs in different nuclear environments in primary haemopoietic cells.
Assuntos
Núcleo Celular/fisiologia , Globinas/genética , Células-Tronco Hematopoéticas/fisiologia , Células Cultivadas , Expressão Gênica , Humanos , Linfócitos/fisiologiaRESUMO
Recent work in the alpha thalassaemia field has started to provide some indication of the mechanisms involved in the very high frequency of the different forms of alpha thalassaemia among the populations of tropical countries, and, at the same time, is starting to define at least some of the mechanisms for its remarkable phenotypic heterogeneity. These diseases continue to provide extremely valuable models for the better understanding of the regulation of the alpha globin genes, and for human molecular pathology in general. The much less common disorders, ATR-16 and ATR-X are also providing valuable information about the spectrum of molecular lesions associated with different forms of mental retardation and about the molecular mechanisms involved in their varying phenotypes.
Assuntos
Talassemia alfa/genética , Variação Genética , Genética Populacional , Genótipo , Hemoglobinas/genética , Humanos , Deficiência Intelectual Ligada ao Cromossomo X/genética , Defeitos do Tubo Neural/genética , Fenótipo , Medicina Tropical , alfa-Globinas/genética , Talassemia alfa/epidemiologiaAssuntos
DNA Helicases , Proteínas de Ligação a DNA/química , Proteínas de Ligação a DNA/genética , Mutação , Proteínas Nucleares , Fatores de Transcrição/química , Fatores de Transcrição/genética , Sequência de Aminoácidos , Animais , Sequência Conservada , Globinas/genética , Humanos , Deficiência Intelectual/genética , Camundongos , Dados de Sequência Molecular , Fenótipo , Homologia de Sequência de Aminoácidos , Síndrome , Proteína Nuclear Ligada ao X , Dedos de Zinco/genética , Talassemia alfa/genéticaRESUMO
We have compared the phenotypes of the two common deletion forms of alpha+-thalassemia by analysis of umbilical cord blood samples from Melanesia. Homozygotes for the leftward, 4.2-kilobase, deletion (-alpha 4.2) had significantly higher levels of Hb Bart's at birth than homozygotes for the rightward, 3.7-kilobase, deletion (-alpha 3.7). Compound heterozygotes for each deletion had intermediate values. Although deletion forms of alpha 0 thalassemia were not found in this survey, nondeletion alpha-thalassemia was present at low frequency. Since the predominant rightward deletion in this population, -alpha 3.7III, entirely removes the alpha 1-gene and the 4.2-kilobase deletion deletes the alpha 2-gene, these data indicate that the alpha 2-globin gene has a higher output than the alpha 1-gene, on single alpha-gene chromosomes.
Assuntos
Hemoglobinas Anormais/genética , Talassemia/genética , Deleção Cromossômica , Regulação da Expressão Gênica , Globinas/genética , Heterozigoto , Homozigoto , Humanos , Melanesia , Fenótipo , Talassemia/sangueRESUMO
Homozygous alpha-thalassemia has the beneficial effect in sickle cell anemia of reducing the hemolytic severity while changing several other hematological parameters. We examined in detail the cellular basis of some of these hematologic alterations. We find that the broad distribution in erythrocyte density and the large proportion of dense cells associated with sickle cell anemia are both reduced with coexisting alpha-thalassemia. Measurements of glycosylated hemoglobin levels as a function of cell density indicate that the accelerated increase in cell density, beyond normal cell aging, in sickle cell anemia is also reduced with alpha-thalassemia. The patients with homozygous alpha-thalassemia and sickle cell disease have slightly lower levels of hemoglobin F than the nonthalassemic sickle cell patients. Examination of hemoglobin F production revealed that the proportion of hemoglobin F containing reticulocytes remained unchanged, as did the proportion of hemoglobin F in cells containing hemoglobin F (F cells). Preferential survival of F cells occurs in sickle cell anemia, with or without alpha-thalassemia, and the slight difference in hemoglobin F levels appear to reflect differences in numbers of circulating F cells. Thus, in sickle cell disease with coexisting alpha-thalassemia, the change in the erythrocyte density profile, possibly due to inhibition of polymerization-related increases in cell density, explains the hematological improvement.
Assuntos
Anemia Falciforme/sangue , Eritrócitos/metabolismo , Talassemia/sangue , Anemia Falciforme/complicações , Anemia Falciforme/genética , Envelhecimento Eritrocítico , Contagem de Eritrócitos , Eritrócitos/classificação , Hemoglobina Fetal/genética , Hematócrito , Humanos , Talassemia/complicações , Talassemia/genéticaRESUMO
A major regulatory element required for expression of the human alpha-globin genes is located 40 kb upstream of the embryonic zeta-globin gene. To understand how this and other locus control region (LCR) elements contribute to high-level expression in erythroid cells, we have performed high-resolution, in vivo dimethyl sulfate footprinting. In addition, we have modified the dimethyl sulfate-based ligation-mediated polymerase chain reaction in vivo footprinting procedure to permit the assessment of interactions at guanine and adenine residues, rather than guanines alone. In vivo footprinting of the human alpha-LCR element carried on chromosome 16 in a mouse erythroleukemia cell environment revealed protein occupancy at GATA-1, AP-1/NF-E2, and CACC/GGTGG motifs, specific differences compared with in vitro protein binding, and distinct changes in one region upon dimethyl sulfoxide-induced cellular maturation. No protein contacts were detected in nonexpressing hepatoma cells. In addition, we have demonstrated that two AP-1 motifs in the alpha-LCR element which are occupied in vivo bind purified mouse NF-E2 protein in vitro. Our data suggest that three proteins, GATA-1, NF-E2, and unknown CACC/GGTGG factors, are minimally required as DNA-binding proteins for the function of LCR-like elements. The juxtaposition and interaction of these factors with each other, and with accessory proteins not directly in contact with DNA, are likely to account for the relative position independence of the upstream globin regulatory elements.
Assuntos
DNA/genética , Globinas/genética , Reação em Cadeia da Polimerase/métodos , Sequências Reguladoras de Ácido Nucleico , Adenina , Animais , Sequência de Bases , Sítios de Ligação , Linhagem Celular , DNA/isolamento & purificação , Impressões Digitais de DNA , Proteínas de Ligação a DNA/metabolismo , Guanina , Humanos , Células Híbridas , Metilação , Camundongos , Dados de Sequência Molecular , Regiões Promotoras GenéticasRESUMO
The major positive regulatory activity of the human alpha-globin gene complex has been localized to an element associated with a strong erythroid-specific DNase I hypersensitive site (HS -40) located 40 kb upstream of the zeta 2-globin mRNA cap site. Footprint and gel shift analyses of the element have demonstrated the presence of four binding sites for the nuclear factor GATA-1 and two sites corresponding to the AP-1 consensus binding sequence. This region resembles one of the major elements of the beta-globin locus control region in its constitution and characteristics; this together with evidence from expression studies suggests that HS -40 is a primary element controlling alpha-globin gene expression.
Assuntos
Globinas/genética , Família Multigênica , Sequências Reguladoras de Ácido Nucleico , Sequência de Bases , DNA , Desoxirribonuclease I/metabolismo , Resistência a Medicamentos/genética , Eletroforese em Gel de Poliacrilamida , Regulação da Expressão Gênica , Humanos , Dados de Sequência Molecular , Neomicina/farmacologia , Mapeamento por Restrição , Transformação GenéticaRESUMO
Testisin is a recently identified human serine protease expressed by premeiotic testicular germ cells and is a candidate tumor suppressor for testicular cancer. Here, we report the characterization of the gene encoding testisin, designated PRSS21, and its localization on the short arm of human chromosome 16 (16p13.3) between the microsatellite marker D16S246 and the radiation hybrid breakpoint CY23HA. We have further refined the localization to cosmid 406D6 in this interval and have established that the gene is approximately 4. 5 kb in length, and contains six exons and five intervening introns. The structure of PRSS21 is very similar to the human prostasin gene (PRSS8) which maps nearby on 16p11.2, suggesting that these genes may have evolved through gene duplication. Sequence analysis showed that the two known isoforms of testisin are generated by alternative pre-mRNA splicing. A major transcription initiation site was identified 97 nucleotides upstream of the testisin translation start and conforms to a consensus initiator element. The region surrounding the transcription initiation site lacks a TATA consensus sequence, but contains a CCAAT sequence and includes a CpG island. The 5'-flanking region contains several consensus response elements including Sp1, AP1 and several testis-specific elements. Analysis of testisin gene expression in tumor cell lines shows that testisin is not expressed in testicular tumor cells but is aberrantly expressed in some tumor cell lines of non-testis origin. These data provide the basis for identifying potential genetic alterations of PRSS21 that may underlie both testicular abnormalities and tumorigenesis.
Assuntos
Mapeamento Cromossômico , Cromossomos Humanos Par 16 , Regulação Enzimológica da Expressão Gênica , Serina Endopeptidases/genética , Processamento Alternativo , Sequência de Aminoácidos , Sequência de Bases , Cosmídeos/genética , DNA/análise , DNA Complementar/metabolismo , Proteínas Ligadas por GPI , Genes Reguladores/genética , Vetores Genéticos , Genoma Humano , Humanos , Masculino , Proteínas de Membrana , Dados de Sequência Molecular , Regiões Promotoras Genéticas/genética , Isoformas de Proteínas/genética , Precursores de RNA/metabolismo , Serina Endopeptidases/biossíntese , Serina Endopeptidases/metabolismo , Transcrição Gênica , Transfecção , Células Tumorais CultivadasRESUMO
Over the past 50 years, many advances in our understanding of the general principles controlling gene expression during hematopoiesis have come from studying the synthesis of hemoglobin. Discovering how the alpha- and beta-globin genes are normally regulated and documenting the effects of inherited mutations that cause thalassemia have played a major role in establishing our current understanding of how genes are switched on or off in hematopoietic cells. Previously, nearly all mutations causing thalassemia have been found in or around the globin loci, but rare inherited and acquired trans-acting mutations are being found more often. Such mutations have demonstrated new mechanisms underlying human genetic disease. Furthermore, they are revealing new pathways in the regulation of globin gene expression that, in turn, may open up new avenues for improving the management of patients with common types of thalassemia.
Assuntos
Regulação da Expressão Gênica , Globinas/genética , Talassemia/terapia , Cromossomos Humanos Par 11/genética , Cromossomos Humanos Par 16/genética , DNA Helicases/genética , DNA Helicases/fisiologia , Epigênese Genética/genética , Regulação da Expressão Gênica no Desenvolvimento , Globinas/biossíntese , Neoplasias Hematológicas/genética , Hematopoese/genética , Humanos , Mutação , Síndromes Mielodisplásicas/genética , Proteínas Nucleares/genética , Proteínas Nucleares/fisiologia , Sequências Reguladoras de Ácido Nucleico , Telômero/genética , Talassemia/genética , Proteína Nuclear Ligada ao X , Talassemia alfa/genéticaRESUMO
During the past 20 years developments in molecular and cellular biology have kindled the hope that one might eventually ameliorate or even cure some serious genetic diseases by repairing or replacing the defective gene. Other articles deal with the formidable problems of isolating pluripotent hematopoietic stem cells; efficiently, safely, and stably transfecting them, and developing transplantation protocols to ensure that the corrected cells supplant the patient's abnormal stem cells after transplantation. Assuming that these hurdles can be overcome, it will also be important to establish the ideal segment of DNA to introduce into stem cells to ensure that, regardless of its position of integration in the genome, the gene in question will be appropriately regulated. In the case of the globin genes this is a particularly difficult task because in order to correct disorders of globin synthesis we need to obtain high levels of stable, tissue- and developmental-stage specific expression. Issues relevant to this problem arising from the analysis of the human beta globin cluster are discussed in the article in this issue by Grosveld. In this article we review our current understanding of how eukaryotic genes might be expressed from their normal chromosomal environment, using the human alpha globin cluster as a specific example. We also discuss how this information might be used in the development of strategies for gene therapy.
Assuntos
Expressão Gênica , Terapia Genética , Globinas/genética , Talassemia alfa/terapia , Animais , Mapeamento Cromossômico , Modelos Animais de Doenças , Humanos , Camundongos , Camundongos Transgênicos , Família Multigênica , MutaçãoRESUMO
We have examined the phenotypic effects of 21 independent deletions from the fully sequenced and annotated 356 kb telomeric region of the short arm of chromosome 16 (16p13.3). Fifteen genes contained within this region have been highly conserved throughout evolution and encode proteins involved in important housekeeping functions, synthesis of haemoglobin, signalling pathways and critical developmental pathways. Although a priori many of these genes would be considered candidates for critical haploinsufficient genes, none of the deletions within the 356 kb interval cause any discernible phenotype other than alpha thalassaemia whether inherited via the maternal or paternal line. These findings contrast with previous observations on patients with larger (> 1 Mb) deletions from the 16p telomere and therefore address the mechanisms by which monosomy gives rise to human genetic disease.
Assuntos
Cromossomos Humanos Par 16 , Monossomia , Telômero , Adolescente , Adulto , Sequência de Bases , Criança , Pré-Escolar , Feminino , Humanos , Hibridização in Situ Fluorescente , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Fenótipo , Deleção de Sequência , Homologia de Sequência do Ácido NucleicoRESUMO
The first step in glycosylphosphatidylinositol (GPI) membrane anchor biosynthesis that is defective in paroxysmal nocturnal haemoglobinuria is mediated by an N-acetylglucosaminyl transferase expressed in the endoplasmic reticulum. Six human genes encode subunits of this enzyme, namely PIG-A, PIG-C, PIG-H, PIG-P, GPI1, and DPM2. Here, the human GPI1 gene is characterised. This gene is organised into eleven exons. The locus was mapped to chromosome 16p13.3 near the haemoglobin alpha chain locus. GPI1 is expressed ubiquitously in human cells and tissues. Expression levels are markedly elevated in haematopoietic tissues (bone marrow, foetal liver). To determine whether human GPI1 is essential for human GPI biosynthesis, antisense RNA was expressed in HEK293 cells. Transfectants exhibited a marked but incomplete decrease in the expression of a GPI-linked reporter protein, confirming that GPI1 is required for efficient GPI biosynthesis. In contrast, expression of GPI-linked proteins is normal in lymphatic cell lines from individuals with the alpha thalassaemia/mental retardation syndrome, which is characterised by large deletions from chromosome 16p removing one of the two GPI1 alleles along with the haemoglobin alpha locus. In conclusion, GPI1 plays an important role in the biosynthesis of GPI intermediates. Due to its autosomal localisation, the heterozygous deletion of GPI1 does not lead to an overt defect in the expression of GPI-linked proteins.
Assuntos
Glicosilfosfatidilinositóis/biossíntese , Proteínas de Membrana/genética , Linhagem Celular Transformada , Mapeamento Cromossômico , Cromossomos Humanos Par 16/genética , DNA Antissenso/genética , Éxons , Feminino , Expressão Gênica , Regulação da Expressão Gênica , Genes/genética , Glicosilfosfatidilinositóis/metabolismo , Heterozigoto , Humanos , Íntrons , Células Jurkat , Masculino , Proteínas de Membrana/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Distribuição TecidualRESUMO
The chromosome-16 and the X-chromosome forms of alpha-thalassemia--ATR-16 and ATR-X--exemplify 2 important causes of syndromal mental retardation. ATR-16 is a contiguous gene syndrome which arises from loss of DNA from the tip of chromosome 16p13.3 by truncation, interstitial deletion, or unbalanced translocation. It provided the first example of a chromosome translocation that could be detected by molecular analysis but not conventional cytogenetics. It also provided the first example of a telomeric truncation giving rise to a complex genetic syndrome. In contrast ATR-X appears to be due to mutations in a trans-acting factor that regulates gene expression. Mutations in transcription factors have recently been identified in a number of genetic diseases (for example, Denys-Drash syndrome, WT1 [19]; pituitary dwarfism, PIT1 [16]; Rubinstein-Taybi syndrome, CBP [20]. Not only is this mechanism proving to be an important cause of complex syndromes but it is providing new perspectives on certain developmental pathways. XH2 may not be a classical transcription factor but it is certainly involved in the regulation of gene expression, exerting its effects on several different genes. It seems likely that other mutations in this class of regulatory proteins will be found in patients with complex disorders including mental retardation. In broader terms the 2 mechanisms described here may prove to be responsible for a significant proportion of mental retardation. However, without a feature such as alpha-thalassemia to pinpoint the area of genome or pathways involved it may prove difficult to identify other, similarly affected genes underlying other forms of mental retardation. As the human genome project and rapid genome analysis evolve this problem should become less of an obstacle. In the meantime, it is very worthwhile to continue looking for unusual clinical associations that may point to critical genes underlying human genetic disorders.
Assuntos
Aberrações Cromossômicas/genética , Cromossomos Humanos Par 16 , Deficiência Intelectual/genética , Cromossomo X , Talassemia alfa/genética , Transtornos Cromossômicos , Mapeamento Cromossômico , Deleção de Genes , Humanos , Mutação , Linhagem , Aberrações dos Cromossomos Sexuais/genética , Síndrome , Transcrição Gênica , Translocação GenéticaRESUMO
The presence of hemoglobin H (beta 4), resulting from a deficiency of alpha-globin chain synthesis, was observed as an acquired characteristic in the red cells of five elderly patients with myeloproliferative disorders or preleukemia. The variability in amount of hemoglobin H and in the alpha/beta globin synthesis ratios in these patients is most likely explained by the relative proportions of normal and abnormal cell populations in the peripheral blood, since some reticulocyte fractions with balanced alpha/beta globin synthesis ratios and others with almost no detectable alpha-chain production could be obtained from these patients. In one patient, the hemoglobin H virtually disappeared despite continuing disease. The amount of cytoplasmic alpha-mRNA matched the proportion of alpha-chain synthesis and, in one patient, this was also true for nuclear RNA. However, extensive analysis of the alpha-globin gene complex by restriction endonuclease mapping revealed no detectable rearrangements of the normal gene organization in any of these patients, suggesting that transcription of each pair of alpha-globin genes on each chromosome 16 is defective. These observations have important implications for both the normal regulation of alpha-globin gene expression and the molecular basis of the underlying defect that is associated with the neoplastic transformation of these cells.
Assuntos
Talassemia/sangue , Idoso , Medula Óssea/patologia , Cromossomos Humanos 16-18 , DNA/análise , Globinas/biossíntese , Globinas/genética , Hemoglobina H/análise , Humanos , Masculino , Pessoa de Meia-Idade , RNA Mensageiro/análise , Talassemia/genéticaRESUMO
Since the identification of the ATRX gene (synonyms XNP, XH2) in 1995, it has been shown to be the disease gene for numerous forms of syndromal X-linked mental retardation [X-linked alpha thalassemia/mental retardation (ATR-X) syndrome, Carpenter syndrome, Juberg-Marsidi syndrome, Smith-Fineman-Myers syndrome, X-linked mental retardation with spastic paraplegia]. An attempt is made in this article to review the clinical spectrum associated with ATRX mutations and to analyse the evidence for any genotype/phenotype correlation.
Assuntos
Anormalidades Múltiplas/genética , Anormalidades Múltiplas/fisiopatologia , DNA Helicases , Proteínas de Ligação a DNA/genética , Ligação Genética , Deficiência Intelectual/genética , Deficiência Intelectual/fisiopatologia , Proteínas Nucleares , Fatores de Transcrição/genética , Cromossomo X/genética , Proteínas de Ligação a DNA/metabolismo , Face/anormalidades , Genótipo , Humanos , Anormalidades Musculoesqueléticas/genética , Anormalidades Musculoesqueléticas/fisiopatologia , Fenótipo , Síndrome , Fatores de Transcrição/metabolismo , Anormalidades Urogenitais/genética , Anormalidades Urogenitais/fisiopatologia , Proteína Nuclear Ligada ao XRESUMO
We report a new kindred containing 4 patients with X-linked alpha-thalassemia/mental retardation syndrome ((ATR-X). Like previously reported ATR-X patients, these children are all genetic males with severe developmental delay and characteristic facial appearance. The genital anomalies are more severe than in most previous cases and have led to a female sex of rearing for 3 of the 4 patients. The hematologic expression is extremely mild and was not demonstrable on routine hematologic studies including hemoglobin electrophoresis, but the three living patients all had hemoglobin H inclusions on brilliant cresyl blue stained peripheral smears. The combination of skewed X-inactivation and haplotype analysis at Xq12-q21.3 confirmed carrier status in the 3 obligate carriers in the kindred and led to identification of an additional carrier. Two other women in the kindred appear to be noncarriers on the basis of normal X-inactivation and/or inheritance of a different Xq12-21.3 haplotype. More widespread use of brilliant cresyl blue staining for HbH inclusions in individuals with the facial phenotype of ATR-X and/or ambiguous genitalia may lead to the identification of more affected patients and improved understanding of the clinical spectrum of ATR-X.